标题
Immunotherapy of melanoma: Present options and future promises
作者
关键词
Melanoma, Immunotherapy, Ipilimumab, Vaccines, Clinical trials
出版物
CANCER AND METASTASIS REVIEWS
Volume 34, Issue 1, Pages 115-128
出版商
Springer Nature
发表日期
2015-01-14
DOI
10.1007/s10555-014-9542-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dendritic cells and cancer immunotherapy
- (2014) Kristen J Radford et al. CURRENT OPINION IN IMMUNOLOGY
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- At the Bench: Adoptive cell therapy for melanoma
- (2014) Walter J. Urba JOURNAL OF LEUKOCYTE BIOLOGY
- Ipilimumab in patients with cancer and the management of dermatologic adverse events
- (2014) Mario E. Lacouture et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
- (2014) Lawrence J Thomas et al. OncoImmunology
- Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
- (2014) Howard L Kaufman et al. Journal for ImmunoTherapy of Cancer
- Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
- (2014) David A Schaer et al. Journal for ImmunoTherapy of Cancer
- Targeting MAPK pathway in melanoma therapy
- (2013) Yabin Cheng et al. CANCER AND METASTASIS REVIEWS
- Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities
- (2013) Barbara Merelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2
- (2013) Chelsea Ma et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis
- (2013) Kira Minkis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
- (2013) Howard L. Kaufman et al. Nature Reviews Clinical Oncology
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab for Patients With Advanced Mucosal Melanoma
- (2013) M. A. Postow et al. ONCOLOGIST
- Psychological Care for People with Melanoma: What, When, Why and How?
- (2013) Nadine A. Kasparian Seminars in Oncology Nursing
- Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes
- (2012) Florian Lang et al. BLOOD PURIFICATION
- Therapy for metastatic melanoma: the past, present, and future
- (2012) Laura Finn et al. BMC Medicine
- BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
- (2012) Richard C. Koya et al. CANCER RESEARCH
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia
- (2012) L. A. Vitale et al. CLINICAL CANCER RESEARCH
- Psychological stress and melanoma: Are we meeting our patients' psychological needs?
- (2012) Nadine Angele Kasparian CLINICS IN DERMATOLOGY
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
- (2012) Alexander M.M. Eggermont et al. JOURNAL OF CLINICAL ONCOLOGY
- IFN- in the Treatment of Melanoma
- (2012) A. A. Tarhini et al. JOURNAL OF IMMUNOLOGY
- U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
- (2012) T. M. Herndon et al. ONCOLOGIST
- The three main stumbling blocks for anticancer T cells
- (2012) Lukas Baitsch et al. TRENDS IN IMMUNOLOGY
- Tumor-Infiltrating Lymphocytes in Melanoma
- (2012) Sylvia Lee et al. Current Oncology Reports
- Cancer vaccines and immunotherapeutics
- (2012) Bengt Jönsson et al. Human Vaccines & Immunotherapeutics
- Autoimmunity associated with immunotherapy of cancer
- (2011) S. M. Amos et al. BLOOD
- White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy
- (2011) J. Weber et al. CLINICAL CANCER RESEARCH
- Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
- (2011) James S. Wilmott et al. CLINICAL CANCER RESEARCH
- Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2011) D. E. Gerber et al. CLINICAL CANCER RESEARCH
- Plasmid DNA Gene Therapy by Electroporation: Principles and Recent Advances
- (2011) Tatsufumi Murakami et al. CURRENT GENE THERAPY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sleep and immune function
- (2011) Luciana Besedovsky et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Treating cancer with genetically engineered T cells
- (2011) Tristen S. Park et al. TRENDS IN BIOTECHNOLOGY
- Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
- (2010) A. Boni et al. CANCER RESEARCH
- Ceramide in Suicidal Death of Erythrocytes
- (2010) Florian Lang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Autoimmunity and treatment outcome in melanoma
- (2010) Marna G Bouwhuis et al. CURRENT OPINION IN ONCOLOGY
- Role of CD27/CD70 pathway of activation in immunity and tolerance
- (2010) Julie Denoeud et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic cells in the skin - potential use for melanoma treatment
- (2008) Sanaa El Marsafy et al. Pigment Cell & Melanoma Research
- CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
- (2008) F Stephen Hodi et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now